Loading...

UNCY - Unicycive Therapeutics, Inc.

Overbought Signal for 02-26-2024
Overbought Stock Signal: UNCY


Loading Chart UNCY

Stock Signal Information


Signal

Overbought Stock Signal: UNCY
Report Date: 02-26-2024
Symbol: UNCY - Unicycive Therapeutics, Inc.
Sector:
Industry:
Overbought Stock Signal: UNCY

  UNCY Technical Analysis

Company Contact

Unicycive Therapeutics, Inc. (UNCY)
4300 El Camino Real
Los Altos, CA 94022
Phone: 650 351 4495
Website: https://www.unicycive.com
CEO: Dr. Shalabh K. Gupta M.D., MPA

UNCY, Unicycive Therapeutics, Inc.

UNCY Unicycive Therapeutics, Inc. Logo Image

NASDAQ, NASDAQ Capital Market


Company Profile

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.